DS
ABEO icon

David Shaw’s Abeona Therapeutics ABEO Stock Holding History

David Shaw’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$353K Sell
57,100
-43,965
-44% -$241K ﹤0.01% 4343
2026
Q1 		$453K Sell
101,065
-4,900
-5% -$24.5K ﹤0.01% 3898
2025
Q4 		$558K Sell
105,965
-20,419
-16% -$103K ﹤0.01% 3872
2025
Q3 		$667K Buy
+126,384
New +$802K ﹤0.01% 3707
2022
Q3 		– Sell
-49,220
Closed -$256K – 5138
2022
Q2 		$256K Sell
49,220
-32,146
-40% -$163K ﹤0.01% 4429
2022
Q1 		$641K Sell
81,366
-19,380
-19% -$133K ﹤0.01% 4221
2021
Q4 		$849K Buy
+100,746
New +$1.85M ﹤0.01% 4063
2021
Q1 		– Sell
-3,331
Closed -$131K – 3985
2020
Q4 		$131K Sell
3,331
-5,043
-60% -$172K ﹤0.01% 3786
2020
Q3 		$214K Buy
8,374
+949
+13% +$59.8K ﹤0.01% 3576
2020
Q2 		$541K Sell
7,425
-1,770
-19% -$122K ﹤0.01% 3315
2020
Q1 		$483K Sell
9,195
-1,123
-11% -$75K ﹤0.01% 3230
2019
Q4 		$843K Buy
10,318
+4,226
+69% +$298K ﹤0.01% 3093
2019
Q3 		$344K Buy
6,092
+5,595
+1,126% +$419K ﹤0.01% 3388
2019
Q2 		$59K Buy
+497
New +$83.3K ﹤0.01% 3578
2016
Q4 		– Sell
-497
Closed -$75K – 3406
2016
Q3 		$75K Buy
+497
New +$48.6K ﹤0.01% 3306
2016
Q1 		– Sell
-520
Closed -$44K – 3367
2015
Q4 		$44K Buy
+520
New +$52.2K ﹤0.01% 3719

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

David Shaw's ABEO Position: Q2 2026 in Review

David Shaw reduced its Abeona Therapeutics (ABEO) stake by 44% in Q2 2026, selling an estimated $241K and leaving 57,100 shares worth $353K. The position accounts for ﹤0.01% of the portfolio, ranked #4343.

David Shaw first reported a position in ABEO in Q4 2015 and has held it in 16 quarters since. The position peaked at $849K in Q4 2021. 126 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • David Shaw held 57,100 shares of Abeona Therapeutics worth $353K as of Q2 2026.
  • David Shaw sold 43,965 Abeona Therapeutics shares in Q2 2026, an estimated $241K.
  • Abeona Therapeutics made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4343 holding.
  • David Shaw first reported a position in Abeona Therapeutics in Q4 2015 and has held it in 16 quarters since.
  • David Shaw's Abeona Therapeutics position peaked at $849K in Q4 2021.
  • 126 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.